Galvin Gaustad & Stein LLC Takes $18.04 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 60,115 shares of the company’s stock, valued at approximately $18,044,000. HCA Healthcare accounts for about 1.6% of Galvin Gaustad & Stein LLC’s portfolio, making the stock its 21st biggest holding.

Several other hedge funds have also recently added to or reduced their stakes in HCA. FMR LLC lifted its stake in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after buying an additional 2,397,883 shares during the period. Darsana Capital Partners LP increased its holdings in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare in the third quarter worth about $150,548,000. Canoe Financial LP increased its holdings in shares of HCA Healthcare by 226,952.9% in the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after acquiring an additional 231,492 shares in the last quarter. Finally, Holocene Advisors LP increased its holdings in shares of HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after acquiring an additional 208,015 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HCA. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Oppenheimer raised their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $385.27.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $324.43 on Thursday. The stock has a 50 day simple moving average of $314.50 and a 200 day simple moving average of $352.84. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a market cap of $82.18 billion, a P/E ratio of 14.57, a PEG ratio of 1.08 and a beta of 1.64.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.